Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

January 2018 - FRMC

Department

Conference Highlights
01/29/2018
A presentation at the PCMH Congress 2017 highlighted how quality evidence-based care models like the patient-centered medical home model (PCMH) and better policies that support small practices in underserved communities are the keys to...
A presentation at the PCMH Congress 2017 highlighted how quality evidence-based care models like the patient-centered medical home model (PCMH) and better policies that support small practices in underserved communities are the keys to...
A presentation at the PCMH...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
During a presentation at the PCMH Congress 2017, Kashyap Patel, MD, an oncologist at Carolina Blood and Cancer Care; Patricia Barrett, MHSA, vice president of product design and support at the NCQA; and Manasi Tirodkar, PhD, MS, a research...
During a presentation at the PCMH Congress 2017, Kashyap Patel, MD, an oncologist at Carolina Blood and Cancer Care; Patricia Barrett, MHSA, vice president of product design and support at the NCQA; and Manasi Tirodkar, PhD, MS, a research...
During a presentation at the...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
According to a presentation at the ASH 2017 Annual Meeting & Exposition, insurance status heavily influenced treatment and survival outcomes among patients with Burkitt lymphoma (BL), but not patients with plasmablastic lymphoma (PBL).
According to a presentation at the ASH 2017 Annual Meeting & Exposition, insurance status heavily influenced treatment and survival outcomes among patients with Burkitt lymphoma (BL), but not patients with plasmablastic lymphoma (PBL).
According to a presentation at...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
Elderly patients with acute myeloid leukemia (AML) faced high health care costs in their first year following diagnosis, according to research presented at the ASH 2017 Annual Meeting & Exposition.
Elderly patients with acute myeloid leukemia (AML) faced high health care costs in their first year following diagnosis, according to research presented at the ASH 2017 Annual Meeting & Exposition.
Elderly patients with acute...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
According to a poster presentation at the ASH 2017 Annual Meeting & Exposition, Neupogen, Granix, and Zarxio were substantially less expensive for preventing neutropenia than Neulesta for an average chemotherapy treatment cycle among patients...
According to a poster presentation at the ASH 2017 Annual Meeting & Exposition, Neupogen, Granix, and Zarxio were substantially less expensive for preventing neutropenia than Neulesta for an average chemotherapy treatment cycle among patients...
According to a poster...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
Researchers at the ASH 2017 Annual Meeting and Exposition found that performing National Comprehensive Cancer Network (NCCN) guideline recommended to detect early signs of myeloma reduces hospital costs.
Researchers at the ASH 2017 Annual Meeting and Exposition found that performing National Comprehensive Cancer Network (NCCN) guideline recommended to detect early signs of myeloma reduces hospital costs.
Researchers at the ASH 2017...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
A study presents at the ASH 2017 Annual Meeting and Exposition highlighted the benefits of a pharmacist-physician professional team in delivering outpatient cancer care.
A study presents at the ASH 2017 Annual Meeting and Exposition highlighted the benefits of a pharmacist-physician professional team in delivering outpatient cancer care.
A study presents at the ASH 2017...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
A study at the ASH 2017 Annual Meeting & Exposition measured the cost-effectiveness of Xarelto compared to the cost-effectiveness of aspirin only. 
A study at the ASH 2017 Annual Meeting & Exposition measured the cost-effectiveness of Xarelto compared to the cost-effectiveness of aspirin only. 
A study at the ASH 2017 Annual...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
Research presented at the ASH 2017 Annual Meeting & Exposition highlighted how costs for autologous stem cell transplantation have decreased over the past decade.
Research presented at the ASH 2017 Annual Meeting & Exposition highlighted how costs for autologous stem cell transplantation have decreased over the past decade.
Research presented at the ASH...
01/29/2018
First Report Managed Care
Conference Insider
01/29/2018
Research at the ASH 2017 Annual Meeting & Exposition found that switching lymphoma patients to a biosimilar could free up budget money in order to cover the cost of expensive cancer therapies.
Research at the ASH 2017 Annual Meeting & Exposition found that switching lymphoma patients to a biosimilar could free up budget money in order to cover the cost of expensive cancer therapies.
Research at the ASH 2017 Annual...
01/29/2018
First Report Managed Care

Advertisement

Advertisement

Advertisement